NCT06209606 2024-12-17Pilot Study Using Changes in Serum BCMA to Determine Disease Progression in Multiple MyelomaOncotherapeuticsPhase EARLY_PHASE1 Recruiting30 enrolled
NCT03110822 2023-11-01A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) PatientsOncotherapeuticsPhase 1 Recruiting134 enrolled